88
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature

, , , , , & show all
Pages 1559-1562 | Published online: 05 Nov 2013

References

  • DeLellisRALloydRVHeitzPUEngCWorld Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine OrgansLyonIARC2004
  • BryantJFarmerJKesslerLJTownsendRRNathansonKLPheochromocytoma: the expanding genetic differential diagnosisJ Natl Cancer Inst2003951196120412928344
  • DettinoAAGuimaraesGCFormigaMPheochromocytoma (PC)/paraganglioma (PG) and sunitinib: Review of reported cases and literature and case report contributionJ Clin Oncol201129Suppl 740621172892
  • GunaldiMKaraIOAfsarCUDumanBBSorafenib in the treatment of metastatic paraganglioma: a case reportJ Clin Oncol201230Supple13523
  • StrumbergDClarkJWAwadaASafety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsOncologist20071242643717470685
  • Abou-AlfaGKSchwartzLRicciSPhase II study of sorafenib in patients with advanced hepatocellular carcinomaJ Clin Oncol2006244293430016908937
  • LlovetJMRicciSMazzaferroVSorafenib in advanced hepato-cellular carcinomaN Engl J Med200835937839018650514
  • ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol200910253419095497
  • EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer20094522824719097774
  • DahiaPLHaoKRogusJNovel pheochromocytoma susceptibility loci identified by integrative genomicsCancer Res2005659651965816266984
  • López-JiménezEGómez-LópezGLeandro-GarcíaLJResearch resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomasMol Endocrinol2010242382239120980436
  • DelmanKAShapiroSEJonaschEWAbdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single centerWorld J Surg20063066566916617420
  • BoedekerCCErlicZRichardSHead and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2J Clin Endocrinol Metab2009941938194419336503
  • Comino-MéndezIGracia-AznárezFJSchiaviFExome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaNat Genet20114366366721685915
  • BuffetAVenisseANauVA decade (2001–2010) of genetic testing for pheochromocytoma and paragangliomaHorm Metab Res20124435936622517557
  • FishbeinLNathansonKLPheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundCancer Genet201220511122429592
  • NoltingSGrossmanABSignaling pathways in pheochromocytomas and paragangliomas: prospects for future therapiesEndocr Pathol201223213322391976
  • EisenhoferGTischlerASde KrijgerRRDiagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratificationEndocr Pathol20122341422180288
  • WilhelmSCarterCLynchMDiscovery and development of sorafenib: a multikinase inhibitor for treating cancerNat Rev Drug Discov2006583584417016424